• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Mylan

Mylan

Mylan Inc MYL 3 Star

Last Price$47.96Day Change (%)2.59%
Open Price$46.70Day Change ($)1.21
Day Range46.56–48.0152-Week Range36.97–57.52

As of Tue 09/16/2014 05:35 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  5. Research
  1. Mylan Signs Agreement with Gilead to Accelerate Access to Hepatitis C Treatments, Sovaldi® (Sofosbuvir) and Single Tablet Regimen of Ledipasvir/Sofosbuvir, in Developing Countries

    Mylan Signs Agreement with Gilead to Accelerate Access to Hepatitis C Treatments, Sovaldi® (Sofosbuvir) and Single Tablet Regimen of Ledipasvir/Sofosbuvir, in Developing Countries

  2. Mylan Launches Generic Precedex™ Injection - Another Key Product Approval

    Mylan Launches Generic Precedex™ Injection - Another Key Product Approval

  3. Mylan Launches First Generic Klor-Con® Extended-Release Tablets

    Mylan Launches First Generic Klor-Con® Extended-Release Tablets

  4. Gilead Announces Generic Licensing Agreements to Increase Access to Hepatitis C Treatments in Developing Countries

    Gilead Announces Generic Licensing Agreements to Increase Access to Hepatitis C Treatments in Developing Countries

  5. U.S. Hot Stocks: Hot Stocks to Watch

    U.S. Hot Stocks: Hot Stocks to Watch

  6. What Migration Can (and Can’t) Do for a Country’s GDP

    Mylan Laboratories MYL reported impressive second-quarter results Wednesday. However, most of the improvement was temporary and will not affect our fair value estimate. The quarter was only slightly better than we expected after excluding a one-time litigation payment and proceeds from a product ...

  7. Jive To Showcase The Power Of Collaborative Workstyles At Sixth Annual JiveWorld Conference

    Jive To Showcase The Power Of Collaborative Workstyles At Sixth Annual JiveWorld Conference

  8. Research and Markets: Global Biosimilars Market Regulations & Pipeline Insight Report

    Research and Markets: Global Biosimilars Market Regulations & Pipeline Insight Report

  9. Research and Markets: Analyzing the Global Market for Active Pharmaceutical Ingredients - 2014

    Research and Markets: Analyzing the Global Market for Active Pharmaceutical Ingredients - 2014

  10. Ipsen: 2014 Half-Year Results and 2014 Objectives

    Ipsen: 2014 Half-Year Results and 2014 Objectives

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.